Latest News & Updates
Breaking News
55 minutes ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Plus Therapeutics Secures Medicare Enrollment for CNSide CSF Diagnostic Platform
Plus Therapeutics' CNSide Diagnostics secures Medicare PTAN, enabling claims submission for its CSF tumor cell enumeration test pending MAC coverage determinations.
Pharma Now Editorial Team
Lantheus Gains Tentative FDA Approval for PNT2003 as First Radioequivalent for Lu 177 Dotatate
FDA tentatively approves PNT2003 as the first radioequivalent for Lu 177 Dotatate, setting a GMP and regulatory benchmark for radiopharmaceutical generics.
Pharma Now Editorial Team
Aclaris Therapeutics Achieves Best-in-Class PK/PD Profile for Bispecific Antibody ATI-052 in Phase 1a Trial
Aclaris ATI-052 Phase 1a data confirm 45-day half-life and quarterly dosing potential, with Phase 2b in asthma targeted for Q4 2026.
Pharma Now Editorial Team
NewAmsterdam Pharma Awaits EMA, MHRA, and Swissmedic Decisions on Obicetrapib in H2 2026
EMA, MHRA, and Swissmedic decisions on obicetrapib expected H2 2026, with Menarini targeting Q4 launches in Germany and the UK.
Pharma Now Editorial Team
